Patient selection for wearable cardioverter defibrillator therapy after myocardial infarction: How can we incorporate compliance into decision-making?

J Cardiovasc Electrophysiol. 2020 May;31(5):1019-1021. doi: 10.1111/jce.14403. Epub 2020 Mar 3.

Authors

Arwa Younis¹, Ilan Goldenberg¹

Affiliation

¹ Cardiology Division, Department of Medicine, Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York.

PMID: 32083370
DOI: 10.1111/jce.14403

No abstract available

Keywords: compliance; sudden cardiac death; wearable cardioverter defibrillator.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Death, Sudden, Cardiac / prevention & control
Defibrillators
Electric Countershock
Humans
Myocardial Infarction* / diagnosis
Myocardial Infarction* / therapy
Patient Selection
Wearable Electronic Devices*